Continue to Site

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Podcast: Boston Scientific CEO Michael Mahoney at the MassDevice Big 100 East

Podcast: Boston Scientific CEO Michael Mahoney at the MassDevice Big 100 East

By

Click to play podcast

Maybe the only mistake Boston Scientific (NYSE:BSX) made when they hired Michael Mahoney as CEO was waiting so long to do it.

After spending much of the last half of a decade in a turnaround that never seemed to get off the ground, the medical device goliath seems to be on the up and up.

Over the past 6 months the company’s share price is up 63% and there are even more signs that the company may be getting its mojo back.

Register for the 2013 MassDevice Big 100 East

However, 10 months ago when he sat down with MassDevice for a long-ranging interview at the MassDevice Big 100 East in Waltham, Mass. Mahoney was still 90-days away from stepping into the top job.

In this podcast, 1 of the 4 we’ll be releasing as we lead up to the 2013 MassDevice Big 100 East on July 16, 2013, Mahoney tells us why he accepted the offer to lead BSX, his leadership philosophy, and where he sees the company and himself over the next 10 years.

If you’re interested in participating in this year’s MassDevice Big 100 East, click here for more information.



In case you missed it

RSS From Medical Design & Outsourcing

  • Synchron’s plan to beat Neuralink in the neuroprosthetic BCI race
    Competing brain-computer interface (BCI) developers Synchron and Neuralink both announced big news this month as they move their dueling neuroimplant technologies forward. The device developers each have FDA investigational device exemption (IDE) for their experimental BCIs. They’ve also got billionaires backing their R&D and regulatory efforts, with Neuralink owned by Elon Musk and Synchron funded… […]
  • How LimFlow’s foot-saving system prevents amputations in patients with no other options
    LimFlow’s breakthrough system for treating chronic limb-threatening ischemia (CLTI) is the first of its kind approved by the FDA for this severe form of peripheral artery disease (PAD). For CLTI patients who have lost blood flow below their knee and have no other suitable endovascular or surgical treatment options available, the LimFlow System for Transcatheter… […]
  • Device strategies to prevent healthcare-associated infections
    Device design, sterilization before use and proper cleaning of reusable equipment can prevent infections and save lives. By Ted Eveleth, AvantGuard Nosocomial infections, also commonly known as healthcare-associated infections (HAIs), are a multibillion-dollar problem and a leading cause of morbidity and mortality around the world. On any given day, about 1 in 31 hospital patients… […]
  • MGS breaks ground on innovation and tech center
    MGS has started construction of its new innovation center at its headquarters campus in Germantown, Wisconsin. The medtech contract manufacturer said the 120,000 ft² facility is scheduled to open by the end of 2024. The MGS expansion will have collaborative workspaces dedicated to ideation and product development, tooling development, automation, and part and process validation,… […]
  • Two-armed surgical robot prototype targets pediatric brain tumors
    Researchers say they’ve developed a surgical robot for removing brain tumors in children, and that it could also offer a less invasive, safer option for adult neurosurgery and other procedures. The trick is using hollow, nitinol robot arms to allow neurosurgeons to swap tools during a tumor resection procedure, said Pierre DuPont. He’s the chief… […]
  • S3 Connected Health joins DiMe’s International Regulatory Pathways project
    NEWS RELEASE: S3 Connected Health joins DiMe’s team of digital health experts in their new project ‘International Regulatory Pathways’ DUBLIN, September 19, 2023 – Building on the success of the Digital Health US Regulatory Pathways, DiMe has assembled a global team of digital health experts, including S3 Connected Health, to support digital health product developers… […]
  • Four steps medtech startups can’t put off
    Developing and commercializing a new medical device is a success worth toasting for medtech startups — but that success also makes it more likely that litigation is in their future. There are steps medtech startups can take to protect themselves down the road, said Greenberg Traurig shareholder Ginger Pigott, a litigator who defends major medical… […]
  • How Biosense Webster aims to expand access to AFib care
    Electrophysiology is “an incredibly vibrant space,” said Nikki Sidi, but access remains a challenge. Nikki Sidi, the U.S. president of Johnson & Johnson’s Biosense Webster, can look at her own company as one of those paving the way in electrophysiology (EP). Its recent milestones include multiple atrial fibrillation (AFib) mapping catheters, including ablation and mapping devices. … […]
  • Tessy Plastics announces CEO and president transitions
    Tessy Plastics today named Stafford Frearson as the medtech supplier’s new president with former President Roland Beck becoming CEO. Frearson joined the contract manufacturer in 1997 and was promoted to his most recent role, VP of engineering, in 2018. He’s now responsible for day-to-day business operations across the plastics company’s 13 locations in the U.S.… […]
  • Accumold details injection molding of thin wall cannulas
    NEWS RELEASE: Injection molding of thin wall cannulas — a lesson in expertise and persistence After 5 years of painstaking work, leading micro molding innovator Accumold has developed a way to micro injection mold thin wall cannulas in very high volumes. Previous to this innovative approach to production, cannulas were typically produced via an extrusion… […]
  • How exposed are Medtronic, Intuitive and other Medtech Big 100 device makers to China?
    As economic concerns shift from the U.S. to China, medical device manufacturers such as Medtronic and Intuitive are monitoring how procedure volumes and new policies affect their businesses. In a new note, William Blair analyst Brandon Vazquez details the exposure of those companies and four more on Medical Design & Outsourcing‘s Medtech Big 100 ranking… […]